In vivo effects of CHOP protocol on onco and suppressor gene expression: Follow-up study

In Vivo

Volumn 12, Issue 5, 1998, Pages 489-493

  Ember, István ^a   Kiss, István ^a   Raposa, Tibor ^a   Nowrasteh, Ghodratollah ^a   Matolcsy, András ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

CHOP; Expression; Oncogene; Secondary tumours; Suppressor gene

Indexed keywords

CARCINOGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; MUTAGENIC AGENT; PREDNISOLONE; VINCRISTINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE H RAS; TUMOR SUPPRESSOR GENE;

EID: 0031739347     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Beer DG and Pilot HC: Proto-oncogene activation during chemically induced hepatocarcinogenesis in rodents. Mutation Res 220: 1-10, 1989.
2. Berger MR, Habs M and Schmahl D: Comparative carcinogenic activity of prednimurtine, chlorambucil, prednisolone and chlorambucil plus prednisolone in Sprague-Dawley rats. Arch Geschwulforsch 55: 429-442, 1985.
3. Bemard D: In: Rich MA (ed), Experimental Leukemogenesis. North-Holland Publ, 159, pp. 1968.
4. Boivin JF and Hutchinson GB: Leukemia and other cancers after radiotherapy and chemotherapy for Hodgkin's disease. Natl Cancer Inst 67: 751-760, 1981.
5. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
6. Ember I, Kiss I, Dezsenyi E, Kertai P: Early Effects of Cyclosporin A on in vivo Oncogene Expression Anticancer Res 14: 1095-1096, 1994.
7. Ember I, Kiss I: In vivo effects of cyclophosphamide on oncogene and suppressor, gene expression in a "follow up" study. Anticancer Res 17: 3593-3598, 1997.
8. Ember I, Raposa T, Varga Cs, Kiss I: Effect of Different Cytostatic Protocols on Oncogene Expression in CBA/Ca Mice. Anticancer Res 15: 1285-1288, 1995.
9. Ember I, Horvàth R, Kiss I; Kertai P: Onkogének expressziójànak es amplifikàciójànak vizsgàlata kémiailag indukàlt patkànyleukémiàban. Magyar Onkológia 3: 119-122, 1996. (In Hungarian)
10. Ember I, Varga Cs, Herczeg L, Raposa T: Szekunder tumorok àllatkisérletes modellje I. In vivo citosztatikus kezelési protokollaok karcinogén-leukemogén hatàsa. Magyar Onkológia 2: 87-97, 1992. (In Hungarian)
11. Ember I, Kiss I, Vermes E: Early effect of Cyclophosphamide in vivo on oncogene action. 25 th Annual Meeting European Environmental Mutagen Society. Noordwijkerhout, Hollandia, 1995.
12. Ember I, Raposa T, Varga Cs, Herceg L, Kiss I: Carcinogenic effects of cytostatic protocols in CBA/Ca Mice. In Vivo 9: 65-70, 1995.
13. I Ember, I Kiss, T Raposa: In vivo effects of COPP protocol on onco and suppressor gene expression in a "follow up" study. In Vivo, 11: 399-402, 1997.
14. I Ember, I Kiss, G Nowrasteh, T Raposa: ABVD therapeutic protocol elevates the oncogene expression in animal model. Anticancer Res (accepted for publication)
15. Fujita T, Maruyama N: Elevated levels of cjun and c-fos transcripts in the aged rat liver. Biochem Biophys Res Common 178.3: 1485-1491, 1991.
16. Kleinberger T, Flint YB, Blank M, Etkin S, Lavi S: Carcinogeninduced transactivation of gene expression. Mol Cell Biol 8/3. 1366-1370, 1988.
17. Li H, Lee GH, Cui L, Liu K, Nomura K, Ohtake K, Kitagawa I: Absence of Ha-ras point mutation at codon 12 in N-methylnitrosourea- induced hepatocellular neoplasms in the rat. J Cancer Res Clin Oncol 116: 331-335, 1990.
18. Penn I: Cancers following cyclosporine therapy. Transplantation 43: 32-35, 1987.
19. Rady P, Kinsella AR, Fox M, Arany I, Kertai P: N-ras Mutation in chemically induced rat brain tumour. Acta Biochem Biophys Hung 24.4: 313-316, 1989.
20. Sakai M, Okuda A, Hatayama I, Sato K, Nishi S, Muramatsu M: Structure and expression of the rat c-jun messenger RNA: Tissue distribution and increase during chemical hepatocarcinogenesis. Cancer Res 49: 5633-5637, 1989.
21. Seguin NB, Escot CH, Moles JP, Blanchard JM, Kerai C, Guilhou J: C-fos and C-jun proto-oncogene expression is decreased in psoriasis: an in situ quantitative analysis. J Invest Dermatol 97. 4: 672-678, 1991.
22. Smith ML, Yeleswarapu L, Locker J, Lombardi B: Expression of p53 mutant protein(s) in diethylnitrosamine-induced foci of enzyme-altered hepatocytes in male Fischre -344 rats. Carcinogenesis 12. 6: 1137-1141, 1991.
23. LA Stanley: Molecular aspects of chemical carcinogenesis: The roles of oncogenes and tumour suppressor genes. Toxicology 96: 173-194, 1995.
24. Teskey, GC, Atkinson BG, Cain DP: Expression of the protooncogene c-fos following electrical killing in the rat. Mol Brain Res 11: 1-10, 1991.
25. Zeller WJ and Schmahl D: Leukemias induced by ethylinitrosourea in Wistar rats: incidence and chemotherapy. Leukemia Res 3: 239-248, 1979.